During the last session, Definitive Healthcare Corp (NASDAQ:DH)’s traded shares were 0.71 million, with the beta value of the company hitting 1.45. At the end of the trading day, the stock’s price was $5.55, reflecting an intraday gain of 2.02% or $0.11. The 52-week high for the DH share is $10.62, that puts it down -91.35 from that peak though still a striking 42.52% gain since the share price plummeted to a 52-week low of $3.19. The company’s market capitalization is $859.78M, and the average intraday trading volume over the past 10 days was 0.67 million shares, and the average trade volume was 595.41K shares over the past three months.
Definitive Healthcare Corp (DH) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 2.71. DH has a Sell rating from 1 analyst(s) out of 10 analysts who have looked at this stock. 4 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 5 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be 0.07.
Definitive Healthcare Corp (NASDAQ:DH) trade information
Definitive Healthcare Corp (DH) registered a 2.02% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 2.02% in intraday trading to $5.55, hitting a weekly high. The stock’s 5-day price performance is 7.77%, and it has moved by 39.45% in 30 days. Based on these gigs, the overall price performance for the year is -39.61%. The short interest in Definitive Healthcare Corp (NASDAQ:DH) is 2.17 million shares and it means that shorts have 2.81 day(s) to cover.
The consensus price target of analysts on Wall Street is $7, which implies an increase of 20.71% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $7 and $7 respectively. As a result, DH is trading at a discount of -26.13% off the target high and -26.13% off the low.
Definitive Healthcare Corp (DH) estimates and forecasts
In the rating firms’ projections, revenue will decrease -0.38% compared to the previous financial year.
As companies strive to predict their financial trajectories, we turn our attention to the forthcoming financial quarter. Here are the insights gathered from industry analysts. Revenue for the current quarter is expected to be 60.59M as predicted by 12 analyst(s). Meanwhile, a consensus of 8 analyst(s) estimates revenue growth to 59.95M by the end of current fiscal year. As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled 65.93M and 63.48M respectively. In this case, analysts expect current quarter sales to shrink by -8.10% and then drop by -5.55% in the coming quarter.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -64.67%. While earnings are projected to return 14.56% in 2025, the next five years will return 2.83% per annum.
DH Dividends
Definitive Healthcare Corp is due to release its next quarterly earnings in March. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Definitive Healthcare Corp (NASDAQ:DH)’s Major holders
Definitive Healthcare Corp insiders own 3.94% of total outstanding shares while institutional holders control 94.47%, with the float percentage being 98.34%. ADVENT INTERNATIONAL CORP/MA is the largest shareholder of the company, while 182.0 institutions own stock in it. As of 2024-06-30, the company held over 62.49 million shares (or 53.2162% of all shares), a total value of $341.22 million in shares.
The next largest institutional holding, with 4.66 million shares, is of VANGUARD GROUP INC’s that is approximately 3.9712% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $25.46 million.
Also, the Mutual Funds coming in first place with the largest holdings of Definitive Healthcare Corp (DH) shares are MFS New Discovery Fund and iShares Russell 2000 ETF . Data provided on Nov 30, 2024 indicates that MFS New Discovery Fund owns about 3.7 shares. This amounts to just over 3.20 percent of the company’s overall shares, with a $20.52 million market value. The same data shows that the other fund manager holds slightly less at 1.52, or about 1.32% of the stock, which is worth about $8.44 million.
